TTM
$7.28B
YoY change
-178.8%
5Y CAGR
—
Peak year (2009)
$10.61B
Cumulative net income
$109.46B
Net Income history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: $7.05B
Net Income growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Latest: -178.8%
Net Income history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| 2025 | $7.05B | -178.8% | +$16.00B | ||
| 2024 | −$8.95B | -211.5% | −$16.97B | ||
| 2023 | $8.03B | +26.8% | +$1.70B | ||
| 2022 | $6.33B | -9.5% | −$667.00M | ||
| 2021 | $6.99B | -177.8% | +$15.99B | ||
| 2020 | −$8.99B | -361.6% | −$12.43B | ||
| 2019 | $3.44B | -30.1% | −$1.48B | ||
| 2018 | $4.92B | +388.6% | +$3.91B | ||
| 2017 | $1.01B | -77.4% | −$3.45B | ||
| 2016 | $4.46B | +184.8% | +$2.89B | ||
| 2015 | $1.56B | -21.9% | −$439.00M | ||
| 2014 | $2.00B | -21.8% | −$559.00M | ||
| 2013 | $2.56B | +30.8% | +$603.00M | ||
| 2012 | $1.96B | -47.2% | −$1.75B | ||
| 2011 | $3.71B | +19.6% | +$607.00M | ||
| 2010 | $3.10B | -70.8% | −$7.51B | ||
| 2009 | $10.61B | +102.2% | +$5.37B | ||
| 2008 | $5.25B | +142.4% | +$3.08B | ||
| 2007 | $2.17B | +36.6% | +$580.00M | ||
| 2006 | $1.58B | -47.2% | −$1.42B | ||
| 2005 | $3.00B | +25.6% | +$612.00M | ||
| 2004 | $2.39B | -23.1% | −$718.00M | ||
| 2003 | $3.11B | +45.3% | +$969.00M | ||
| 2002 | $2.14B | -55.8% | −$2.70B | ||
| 2001 | $4.83B | +2.6% | +$123.00M | ||
| 2000 | $4.71B | +13.1% | +$544.00M | ||
| 1999 | $4.17B | +32.7% | +$1.03B | ||
| 1998 | $3.14B | -2.0% | −$64.00M | ||
| 1997 | $3.21B | +12.5% | +$355.00M | ||
| 1996 | $2.85B | +57.3% | +$1.04B | ||
| 1995 | $1.81B | -1.6% | −$30.00M | ||
| 1994 | $1.84B | -6.0% | −$117.00M | ||
| 1993 | $1.96B | -0.2% | −$3.00M | ||
| 1992 | $1.96B | -4.6% | −$94.00M | ||
| 1991 | $2.06B | +17.6% | +$308.00M | ||
| 1990 | $1.75B | +134.0% | +$1.00B | ||
| 1989 | $747.00M | -40.4% | −$507.00M | ||
| 1988 | $1.25B | +17.4% | +$186.00M | ||
| 1987 | $1.07B | — | — |
- 2025$7.05B-178.8%
- 2024−$8.95B-211.5%
- 2023$8.03B+26.8%
- 2022$6.33B-9.5%
- 2021$6.99B-177.8%
- 2020−$8.99B-361.6%
- 2019$3.44B-30.1%
- 2018$4.92B+388.6%
- 2017$1.01B-77.4%
- 2016$4.46B+184.8%
- 2015$1.56B-21.9%
- 2014$2.00B-21.8%
- 2013$2.56B+30.8%
- 2012$1.96B-47.2%
- 2011$3.71B+19.6%
- 2010$3.10B-70.8%
- 2009$10.61B+102.2%
- 2008$5.25B+142.4%
- 2007$2.17B+36.6%
- 2006$1.58B-47.2%
- 2005$3.00B+25.6%
- 2004$2.39B-23.1%
- 2003$3.11B+45.3%
- 2002$2.14B-55.8%
- 2001$4.83B+2.6%
- 2000$4.71B+13.1%
- 1999$4.17B+32.7%
- 1998$3.14B-2.0%
- 1997$3.21B+12.5%
- 1996$2.85B+57.3%
- 1995$1.81B-1.6%
- 1994$1.84B-6.0%
- 1993$1.96B-0.2%
- 1992$1.96B-4.6%
- 1991$2.06B+17.6%
- 1990$1.75B+134.0%
- 1989$747.00M-40.4%
- 1988$1.25B+17.4%
- 1987$1.07B—
Net Income values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current net income (TTM) is $7.28B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual net income for Bristol-Myers Squibb (BMY) came in at $7.05B – plunged 178.8% year-over-year.
Across 2015–2025 (10 years), Bristol-Myers Squibb net income produced a CAGR of +16.2% – with mixed annual results across the window.
Bristol-Myers Squibb net income peaked at $10.61B in 2009; the latest annual figure is $7.05B in 2025 (33.5% below peak).
$10.61B stands as the all-time-high annual net income, posted in 2009, against a low of −$8.99B during 2020.
Bristol-Myers Squibb Net Income by Year
Bristol-Myers Squibb Net Income 2025: $7.05B
Bristol-Myers Squibb net income in 2025 was $7.05B, plunged 178.8% below 2024.
Bristol-Myers Squibb Net Income 2024: −$8.95B
2024's net income for Bristol-Myers Squibb came in at −$8.95B, plunged 211.5% below 2023.
Bristol-Myers Squibb Net Income 2023: $8.03B
Bristol-Myers Squibb posted net income of $8.03B in 2023, grew 26.8% from 2022.
Bristol-Myers Squibb Net Income 2022: $6.33B
In 2022, Bristol-Myers Squibb reported net income of $6.33B, declined 9.5% below 2021.
Bristol-Myers Squibb Net Income 2021: $6.99B
Bristol-Myers Squibb net income in 2021 was $6.99B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Net Income
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation